Categories: News

Genflow Biosciences PLC Announces Holding(s) in Company

LONDON, UK / ACCESSWIRE / May 10, 2024 / TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BP2C3V08

Issuer Name

GENFLOW BIOSCIENCES PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Jonathan Mark Swann

City of registered office (if applicable)

rickmansworth

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

5. Date on which the threshold was crossed or reached

09-May-2024

6. Date on which Issuer notified

10-May-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A) % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

5.030000

0.000000

5.030000

17586000

Position of previous notification (if applicable)

4.830000

0.000000

4.830000

16874000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible) Number of direct voting rights (DTR5.1) Number of indirect voting rights (DTR5.2.1) % of direct voting rights (DTR5.1) % of indirect voting rights (DTR5.2.1)

GB00BP2C3V08

17586000

0

5.030000

0.000000

Sub Total 8.A

17586000

5.030000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument Expiration date Exercise/conversion period Number of voting rights that may be acquired if the instrument is exercised/converted % of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument Expiration date Exercise/conversion period Physical or cash settlement Number of voting rights % of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person Name of controlled undertaking % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher than the notifiable threshold Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

NONE

12. Date of Completion

10-May-2024

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Genflow Biosciences PLC

View the original press release on accesswire.com

Staff

Recent Posts

Semler Scientific® Announces Additional Bitcoin Purchases

SANTA CLARA, Calif., June 6, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer…

3 hours ago

Orange County Soccer Club Taps GENEFIT for Comprehensive Genes-Based Performance and Recovery Insights

The sports-tech innovator powered by 3X4 Genetics will work closely with OCSC coaching, training, and…

3 hours ago

PHTI Study Confirms Positive Clinical and Economic Outcomes for Physical Therapist-Guided Virtual MSK Solutions, Including RecoveryOne

WALNUT CREEK, Calif., June 6, 2024 /PRNewswire/ -- RecoveryOne, a leading virtual musculoskeletal (MSK) care provider…

3 hours ago

Notification of Data Security Incident Best Health Physical Therapy, LLC

GROTON, Conn., June 6, 2024 /PRNewswire/ -- On February 26, 2024, Best Health Physical Therapy,…

3 hours ago

NextSense Honored as World Economic Forum Technology Pioneer

MOUNTAIN VIEW, Calif., June 6, 2024 /PRNewswire/ -- NextSense is proud to announce that it…

3 hours ago